drugset

drugset / Trial / NCT04220515

Inactivated Poliomyelitis Vaccine Made From Sabin Strain

NCT04220515 ↗

Phase 4 Completed 49731 enrolled Institute of Medical Biology, Chinese Academy of Medical Sciences Shanghai Center for Disease Control and Prevention · collab

NaSingle-groupOpen-labelPrevention

Summary

This study includes both active and passive safety monitoring in large pupulations for the phase IV safety monitoring study of Inactivated Poliomyelitis Vaccine Made From Sabin Strain (sIPV).

Timeline

Start: 2018-02-08
Primary completion: 2019-08-08
Completion: 2019-10-14

Publications

Jiang R, Liu X, Sun X, Wang J, Huang Z, Li C, Li Z, Zhou J, Pu Y, Ying Z, Yin Q, Zhao Z, Zhang L, Lei J, Bao W, Jiang Y, Dou Y, Li J, Yang H, Cai W, Deng Y, Che Y, Shi L, Sun M. Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population. Vaccine. 2021 Mar 1;39(9):1463-1471. doi: 10.1016/j.vaccine.2021.01.027. Epub 2021 Jan 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Inactivated Poliomyelitis Vaccine Made From Sabin Strain	Vaccine	30 unknown	—
Subject	Inactivated Poliomyelitis Vaccine Made From Sabin Strain	Vaccine	32 unknown	—
Subject	Inactivated Poliomyelitis Vaccine Made From Sabin Strain	Vaccine	45 unknown	—

Indications